KalVista reports inducement grants under Nasdaq listing rule
PremiumThe FlyKalVista reports inducement grants under Nasdaq listing rule
1M ago
KalVista submits additional MAAs for sebetralstat for treatment of HAE
Premium
The Fly
KalVista submits additional MAAs for sebetralstat for treatment of HAE
1M ago
KalVista initiated with a Buy at JonesResearch
Premium
The Fly
KalVista initiated with a Buy at JonesResearch
1M ago
KalVista announces FDA approval of NDA for sebetralstat
PremiumThe FlyKalVista announces FDA approval of NDA for sebetralstat
2M ago
Is KALV a Buy, Before Earnings?
Premium
Pre-Earnings
Is KALV a Buy, Before Earnings?
2M ago
KalVista’s sebetralstat application validated by European Medicines Agency
Premium
The Fly
KalVista’s sebetralstat application validated by European Medicines Agency
3M ago
Is KALV a Buy, Before Earnings?
PremiumPre-EarningsIs KALV a Buy, Before Earnings?
4M ago
KalVista begins trial for sebetralstat in children with hereditary angioedema
Premium
The Fly
KalVista begins trial for sebetralstat in children with hereditary angioedema
5M ago
KalVista submits New Drug Application to FDA for sebetralstat
Premium
The Fly
KalVista submits New Drug Application to FDA for sebetralstat
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100